Australian government funds $1M for development of Covax-19® vaccine (MTPConnect)

The pioneering team at Vaxine who developed the world’s first swine flu vaccine in 2009, has been awarded funding of $1 million dollars from the Biomedical Translation Bridge (BTB) program, an initiative of the Medical Research Future Fund operated by MTPConnect, to help advance Vaxine’s state-of-the-art COVID-19 vaccine candidate called Covax-19®.

Sharen Pringle, Vaxine’s Business Manager said the Vaxine team are very proud to be leading the Australian effort in development of COVID-19 vaccines.

Full link ot the article